Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for microvascular function in obese adults with elevated blood pressure
NL-OMON45212Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of eplerenone in hypertension (HTN) and insulin resistance (IR), sponsored by Maastricht University. Started Jan 2014; status: active, not recruiting.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)insulin resistance (IR)
Beyond the preview
Go deeper on NL-OMON45212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45212.